Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
BACKGROUND: Attention-Deficit/Hyperactivity Disorder (ADHD) is a common psychiatric disorder in children and adolescents. Immediate-release methylphenidate (IR-MPH) is the medical treatment of first choice. The necessity to use several IR-MPH tablets per day and associated potential social stigma at school often leads to reduced compliance, sub-optimal treatment, and therefore economic loss. Replacement of IR-MPH with a single-dose extended release (ER-MPH) formulation may improve drug response and economic efficiency. OBJECTIVE: To evaluate the cost-effectiveness from a societal perspective o... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2015 |
Reihe/Periodikum: | van der Schans , J , Kotsopoulos , N , Hoekstra , P J , Hak , E & Postma , M J 2015 , ' Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate ' , PLoS ONE , vol. 10 , no. 5 , e0127237 . https://doi.org/10.1371/journal.pone.0127237 |
Schlagwörter: | DEFICIT-HYPERACTIVITY DISORDER / MULTIMODAL TREATMENT / ADHD / NETHERLANDS / EPIDEMIOLOGY / UTILITIES / EFFICACY / PATTERNS / OUTCOMES / LIFE |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27210812 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/b120274f-abc4-456c-bb40-92f2b0eba430 |